Press release
Diabetic Gastroparesis Treatment Market Poised to Hit $5.13 Billion by 2029 with Accelerating Growth Trends
Diabetic Gastroparesis Treatment
Diabetic Gastroparesis Treatment Market Size Growth Forecast: What to Expect by 2025?
In the past few years, there has been a consistent expansion in the market size of diabetic gastroparesis treatment. The market, which stands at $3.89 billion in 2024, is projected to increase to $4.07 billion in 2025, witnessing a compound annual growth rate (CAGR) of 4.5%. The growth observed in the historical period is due to factors such as a rise in diabetes cases, limited available therapies, heightened awareness and diagnosis, along with advancements in healthcare infrastructure.
How Will the Diabetic Gastroparesis Treatment Market Size Evolve and Grow by 2029?
The market for treatment of diabetic gastroparesis is anticipated to witness robust expansion in the coming years. It is predicted to reach a value of $5.13 billion in 2029, with a Compound Annual Growth Rate (CAGR) of 6.0%. Factors contributing to the growth during the forecast period include advancements in precision medicine and personalized therapies, an increase in the diabetic population, heightened research and development activities and shifts in regulatory frameworks. The forecast also points towards significant trends, including technological enhancements in treatment approaches, introduction of new therapies, emphasis on managing symptoms, adoption of telemedicine and remote monitoring, and interventions in gut microbiome.
View the full report here:
https://www.thebusinessresearchcompany.com/report/diabetic-gastroparesis-treatment-global-market-report
What Drivers Are Propelling the Growth of Diabetic Gastroparesis Treatment Market Forward?
The escalating incidence of diabetes is anticipated to spur the expansion of the diabetic gastroparesis treatment market in the future. Diabetes prevalence relates to the fraction or percentage of individuals diagnosed with diabetes at any given time. The primary objective of diabetic gastroparesis treatment is to control the associated symptoms and complications, which are prevalent in diabetic individuals. For example, a report from The British Diabetic Association a UK-based diabetes charity, in April 2023 revealed that 4.3 million people in the UK live with diabetes. Moreover, over 2.4 million UK residents are highly vulnerable to developing type 2 diabetes, with 2021-22 registration numbers standing at 148,951. As a result, the rising incidence of diabetes is fuelling the progress of the diabetic gastroparesis treatment market.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12580&type=smp
Which Emerging Trends Are Transforming the Diabetic Gastroparesis Treatment Market in 2025?
The development of new treatments is an emerging trend in the diabetic gastroparesis treatment market. In order to maintain their standing in the market, key players are focusing on the creation of new products. For example, in June 2023, the U.S. Food and Drug Administration, a US-based government agency, gave its approval for two medications traditionally used to treat type 2 diabetes in adults for use in children aged ten and above. The approval of Empagliflozin (Jardiance) and Synjardy (Empagliflozin and Metformin Hydrochloride) signifies the availability of a new category of type 2 diabetes drugs for children. Synjardy, a combination of empagliflozin and metformin, is used to get a better grip on glycemic control in type 2 diabetes patients. This combination offers a more comprehensive approach to managing blood sugar than when either of the medicines is used individually.
What Are the Key Segments in the Diabetic Gastroparesis Treatment Market?
The diabetic gastroparesis treatment market covered in this report is segmented -
1) By Treatment: Medication, Surgery
2) By Route Of Administration: Oral, Injectables
3) By Indication: Compensated Gastroparesis, Gastric Failure
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Other Distribution Channels
5) By End User: Hospitals, Homecare, Specialty Clinics, Other End Users
Subsegments:
1) By Medication: Prokinetic Agents, Antiemetics, Antidepressants, Other Pharmacological Therapies
2) By Surgery: Gastric Electrical Stimulation, Surgical Procedures For Gastric Drainage, Other Surgical Interventions
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=12580&type=smp
Who Are the Key Players Shaping the Diabetic Gastroparesis Treatment Market's Competitive Landscape?
Major companies operating in the diabetic gastroparesis treatment market include Pfizer Inc., F. Hoffmann-La Roche Ltd., Ipca Laboratories Ltd., Abbott Laboratories, AstraZeneca plc, Medtronics plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Janssen Global Services LLC, Boston Scientific Corporation, Fresenius Kabi AG, Bausch Health Companies Inc., Salix Pharmaceuticals Inc., Ironwood Pharmaceuticals Inc., Wockhardt Ltd., ANI Pharmaceuticals Inc., Endologic LLC, Vanda Pharmaceuticals Inc., Rhythm Pharmaceuticals Inc., Theravance Biopharma Inc., Neurogastrx Inc., Evoke Pharma Inc., CinRx Pharma LLC
What Geographic Markets Are Powering Growth in the Diabetic Gastroparesis Treatment Market?
North America was the largest region in the diabetic gastroparesis treatment market in 2024, and is expected to be the fastest-growing region in the forecast period. The regions covered in the diabetic gastroparesis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12580
This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Diabetic Gastroparesis Treatment Market Poised to Hit $5.13 Billion by 2029 with Accelerating Growth Trends here
News-ID: 4099021 • Views: …
More Releases from The Business Research Company
Unlocking Opportunities in the Tyrosine Kinase Inhibitors Market: 2025-2034 Fore …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Tyrosine Kinase Inhibitors Industry Market Size Be by 2025?
The market for tyrosine kinase inhibitors has seen robust growth in recent times. The market is predicted to expand from $58.03 billion in 2024 to $62.66 billion in 2025, marking a compound annual growth rate (CAGR) of…
Sustained Release Excipients Market Advances With Product Innovation Industry Tr …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Sustained Release Excipients Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In recent times, the market size of sustained release excipients has seen significant growth. It's projected to increase from $1.4 billion in 2024 to $1.51 billion in 2025, exhibiting a Compound Annual Growth Rate…
Surge In Cancer Cases Fuels Expansion Of The RNA-Targeting Small Molecule Therap …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the RNA Targeting Small Molecules Therapeutics Market Size By 2025?
In recent years, the market size of RNA targeting small molecules therapeutics has witnessed substantial growth. The market, which is estimated to be worth $6.1 billion in 2024, is projected to increase to $7.83 billion in…
Surge In Autoimmune Diseases Fuels Remicade Biosimilar Market Growth Emerges as …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Remicade Biosimilar Market Through 2025?
In recent times, we've seen significant expansion in the remicade biosimilar market. Projected growth from 2024's $3.95 billion to $4.89 billion in 2025 indicates a compound annual growth rate (CAGR) of 23.8%. This rise during the historic…
More Releases for Diabetic
Diabetic Socks Market Dynamics Shaped by Rising Diabetic Population - Persistenc …
The diabetic socks market is gaining significant traction worldwide, driven by the rising prevalence of diabetes and related complications such as diabetic neuropathy and foot ulcers. Designed specifically to cater to the needs of diabetic patients, these socks play a crucial role in foot protection by preventing blistering, reducing moisture accumulation, and providing cushioning to minimize the risk of ulcers. This article delves deeply into the diabetic socks market, exploring…
Leading Element Driving Change in the Diabetic Footwear Market in 2025: Rising D …
Which drivers are expected to have the greatest impact on the over the diabetic footwear market's growth?
The surge in people with diabetes will spur the expansion of the diabetic footwear market in the future. Diabetes, characterised by high blood sugar levels, is a long-term health issue. Diabetic footwear can prevent severe foot-related issues caused by diabetes and offer several advantages such as enhanced blood flow, ample space for the toes,…
Diabetic Food Market
Future Market Insights (FMI) delivers key insights on the global diabetic food market in its latest report titled “Diabetic Food Market: Global Industry Analysis and Opportunity Assessment, 2014 – 2020”. The global diabetic food market is expected to amplify at a CAGR of 5.9% during the forecast period in terms of value due to various factors, regarding which FMI offers fundamental insights in detail in this report.
On the basis of…
Diabetic Food Market
Diabetes refers to a metabolic disease which leads to high blood sugar levels. The main cause behind diabetes is the insufficient insulin or no response in the body cells where the insulin is produced. Diabetic foods are dietary products rich in carbohydrates and sugar content. They help in controlling rising blood glucose. Diabetic food is low in calorie sweeteners and diet beverages. These products are consumed by diabetic patients and…
Demand for Diabetic Socks Due to Rising Prevalence of Diabetic Neuropathy Expect …
According to the latest market report published by Persistence Market Research titled ‘Diabetic Socks Market: Global Industry Analysis 2012-2016 and Forecast 2017-2025,’ the global diabetic socks market is expected to expand at a CAGR of approximately 4.8% during the forecast period 2017-2025.
To know key findings Request Sample Report @: https://www.persistencemarketresearch.com/samples/19282
Global Diabetic Socks Market: Factors Impacting the Market
The primary factors driving the growth of the global diabetic socks market are increasing…
Diabetic Food Market -
In recent times, diabetes has emerged as one of the most challenging health conditions across the world. According to the WHO, a total of 415 million cases of diabetes were reported globally in 2015. The count is rising at an alarming rate and is expected to reach 642 million in the next 25 years. Till now no medication has been found that can completely cure diabetes. It can only be…
